Biotricity Stock Forecast, Price & News

Biotricity (OTCMKTS:BTCY) Frequently Asked Questions

Is Biotricity a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Biotricity stock.
View analyst ratings for Biotricity or view top-rated stocks.

How has Biotricity's stock price been impacted by Coronavirus (COVID-19)?

Biotricity's stock was trading at $1.2250 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BTCY shares have increased by 225.7% and is now trading at $3.99.
View which stocks have been most impacted by COVID-19.

When is Biotricity's next earnings date?

Biotricity is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Biotricity.

What price target have analysts set for BTCY?

4 brokerages have issued 1-year price objectives for Biotricity's shares. Their forecasts range from $6.00 to $7.00. On average, they expect Biotricity's share price to reach $6.75 in the next twelve months. This suggests a possible upside of 69.2% from the stock's current price.
View analysts' price targets for Biotricity or view top-rated stocks among Wall Street analysts.

Who are Biotricity's key executives?

Biotricity's management team includes the following people:

• Waqaas Al-Siddiq, Chairman, President & Chief Executive Officer
• John Ayanoglou, Chief Financial Officer
• Spencer LaDow, Vice President-Engineering
• Amir Ali, Chief Development Officer

Who are some of Biotricity's key competitors?

Some companies that are related to Biotricity include Central Puerto (CEPU), CBRE Acquisition (CBAH), Ellomay Capital (ELLO), Athena Technology Acquisition (ATHN), Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (EDN), Alaska Power & Telephone (APTL), Ocean Power Technologies (OPTT), Eco Wave Power Global AB (publ) American Depositary Shares (WAVE), Summer Energy (SUME), Aqua Power Systems (APSI), Principal Solar (PSWW), Premier (PRHL), Transtech Industries (TRTI), Commerce Energy Group (CMNR) and EnSync (ESNC).
View all of BTCY's competitors.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), (CGC), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

What is Biotricity's stock symbol?

Biotricity trades on the OTCMKTS under the ticker symbol "BTCY."

Who are Biotricity's major shareholders?

Biotricity's stock is owned by a variety of institutional and retail investors. Top institutional investors include HighTower Advisors LLC (0.13%), Moors & Cabot Inc. (0.08%), Geode Capital Management LLC (0.07%), Magnus Financial Group LLC (0.04%), Citadel Advisors LLC (0.03%) and Signature Wealth Management Partners LLC (0.03%).
View institutional ownership trends for Biotricity.

Which major investors are buying Biotricity stock?

BTCY stock was bought by a variety of institutional investors in the last quarter, including HighTower Advisors LLC, Moors & Cabot Inc., Geode Capital Management LLC, Magnus Financial Group LLC, Citadel Advisors LLC, Signature Wealth Management Partners LLC, StoneX Group Inc., and National Asset Management Inc..
View insider buying and selling activity for Biotricity or or view top insider-buying stocks.

How do I buy shares of Biotricity?

Shares of BTCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biotricity's stock price today?

One share of BTCY stock can currently be purchased for approximately $3.99.

How much money does Biotricity make?

Biotricity has a market capitalization of $196.03 million.

How many employees does Biotricity have?

Biotricity employs 24 workers across the globe.

What is Biotricity's official website?

The official website for Biotricity is www.biotricity.com.

How can I contact Biotricity?

The company can be reached via phone at (650) 832-1626.